Why NOW is the Best Time to Get into the NIV Business

Published in Respiratory & Sleep on April 11, 2022

There is currently a large opportunity in the respiratory market for non-invasive ventilation (NIV). Is your business taking advantage of this opportunity?

Who should get into the vent business?

DME providers that serve respiratory patients such as Oxygen or CPAP patients would be good candidates to look at a program such as NIV to better serve their patients in the community. DMEs will need to have Respiratory Therapists involved with the patient care coordination but could work with a telerespiratory company such as rtNOW to assist with follow-up telehealth visits.

To figure out if NIV would good for your business, take a look at the NIV Profitability Calculator that our experts in VGM Respiratory have put together.

DMEs can distinguish themselves apart from their competitors by accepting these patients and measuring patient outcomes by using Encore Healthcare. Encore Healthcare is a software that helps build individual care plans to monitor patient outcomes to reduce hospital readmissions and reduce healthcare spend.

What resources are available to help?

Many DMEs have not gotten into this business before due to cost of ownership issues, perceived lack of staff, and also fear of improperly billing audits. VGM Respiratory has put together many resources to help DMEs get into the business. DMEs can utilize Trace Medical to rent the equipment and rtNOW for telerespiratory assistance for vent follow-ups and vent checks.

The Members Only portal at vgm.com has a plethora of resources available to our members under Forms & Documents including profitability calculators, education materials for your staff, vent checklists from The van Halem Group, policies & procedures, a Home Ventilation Management Program guide, and a guide for using End-Tidal CO2 to identify patients who benefit.

If you’re concerned about the documentation requirements, The van Halem Group can help. The van Halem Group’s team of expert clinicians can review provider documentation prior to dispensing to determine if all coverage requirements have been met, reducing the risk of claim denials or overpayments. These prescreen reviews are designed to not only provide valuable information, but can also be used as an educational tool for referral sources. As an independent clinical reviewer, The van Halem Group’s recommendations and clinical insight will benefit referral sources

If you have questions about NIV or are interested in discussing this opportunity further, contact your VGM account manager.


TAGS

  1. business development
  2. reimbursement
  3. respiratory
  4. software
  5. telehealth
  6. the van halem group

From Our Experts

Optimizing Inventory with Trace Medical thumbnail Optimizing Inventory with Trace Medical In this episode of Industry Matters, learn about Trace Medical's history and growth to the ventilator rental company in the U.S., how they navigated COVID-19, and why you should be looking to Trace Medical to help optimize inventory, take advantage of asset flexibility, and increase EBIDTA margins. Is a Global PAP Shortage Enough to Make You Diversify Your Business? thumbnail Is a Global PAP Shortage Enough to Make You Diversify Your Business? Can your business continue to weather the global PAP shortage, and if so, for how long? Are you losing referrals to other providers that can source PAP devices? Now is the time to take advantage of an emerging market: home ventilation. You don't want to miss the buck on this opportunity. Positive Trends and Getting a Win in HME thumbnail Positive Trends and Getting a Win in HME Boone Lockard, director of VGM Respiratory, explains why there's a light at the end of the tunnel for the CPAP market, how the new NCD for oxygen will be a “big win,” and why there's promise in resurging value-based care models in a recent interview with HME News. Outcomes Driven by Clinical Respiratory Software and Analytics thumbnail Outcomes Driven by Clinical Respiratory Software and Analytics Patient outcomes are rapidly emerging as a powerful growth strategy. Collecting patient-focused measures and transforming that data into clinical metrics is the key to success in the respiratory DME model going forward. End-Tidal CO2 (EtCO2) Monitoring in the Home thumbnail End-Tidal CO2 (EtCO2) Monitoring in the Home The End-tidal CO2 (EtCO2) test provides a non-invasive measurement of the patient's ventilation, circulation, and metabolism. Ron Hosp discusses EtCO2 and how it can benefit your company. How Investing in DME Could Save Billions of Dollars thumbnail How Investing in DME Could Save Billions of Dollars VGM and Leitten Consulting recently published an updated study, “Competitive Bidding -A Decade Focused on the Wrong Prize: The Case for Medicare Investment in DME in 2021.” The Tipping Point of Respiratory Outcomes in the Home thumbnail The Tipping Point of Respiratory Outcomes in the Home VGM's Dave Lyman talks with CEO of Encore Health Care, Zach Gantt, about the importance of respiratory outcomes in the DME world. How the Pandemic is Impacting Sleep and How a Ring Can Help Monitor Oxygen Levels thumbnail How the Pandemic is Impacting Sleep and How a Ring Can Help Monitor Oxygen Levels In this episode of Industry Matters Ronda Buhrmester, Senior Director of Payer Relations at VGM, interviews Dr. Meir Kryger, Professor of Medicine at Yale University of Medicine, about the impact COVID-19 had, and is having on sleep, as well how the BodiMetrics CIRCUL Sleep and Fitness Ring can be used to accurately track oxygen levels.